Utility of extracorporeal membrane oxygenation for early graft failure following heart transplantation in infancy

Citation
Mb. Mitchell et al., Utility of extracorporeal membrane oxygenation for early graft failure following heart transplantation in infancy, J HEART LUN, 19(9), 2000, pp. 834-839
Citations number
13
Categorie Soggetti
Cardiovascular & Respiratory Systems
Journal title
JOURNAL OF HEART AND LUNG TRANSPLANTATION
ISSN journal
10532498 → ACNP
Volume
19
Issue
9
Year of publication
2000
Pages
834 - 839
Database
ISI
SICI code
1053-2498(200009)19:9<834:UOEMOF>2.0.ZU;2-G
Abstract
Background: Extracorporeal membrane oxygenation (ECMO) is widely used for p ostcardiotomy cardiogenic shock in children. However, the efficacy of ECMO for early post-heart transplant graft failure in infants has not been repor ted. Our aims were to determine: (1) the utility of ECMO in infants with se vere donor-heart dysfunction, (2) predictors for requiring ECMO, and (3) th e long-term outcome of surviving ECMO patients. Methods: All infants (age < 6 months at listing) undergoing heart transplan tation were reviewed. Diagnostic categories were hypoplastic left heart syn drome (HLHS) and non-HLHS (complex congenital heart disease and cardiomyopa thies). Continuous and categorical comparisons were by Wilcoxon's rank sum test and Fisher's exact test respectively. Results: 14 (12 HLHS, 2 non-HLHS) of 63 (46 HLHS, 17 non-HLHS) infants were placed on ECMO. Ten patients (71%) were successfully weaned from ECMO and 8 (57%) were discharged alive. All ECMO hospital survivors remain alive (me an followup 36.2 +/- 21.4 months, range 13.1-77.6 months). Mean duration of ECMO support was 68 hours in weaned patients vs 144 hours (p = 0.19) in no nweaned patients, and 64 hours in survivors vs 123 hours (p = 0.35) in nons urvivors. ECMO deaths were due to sepsis (n = 3), intractable pulmonary hyp ertension (n = 2), and intracranial bleed (n : 1). Neurologic deficits occu rred in 2 survivors. Median ICU and hospital stays for ECMO survivors were 29 and 33 days vs 7 (p = 0.0003) and 9 (p = 0.0004) days for non-ECMO patie nts. Age listed, age transplanted, wait time, body weight, donor/recipient weight ratio, total ischemia time, and diagnosis did not predict the need f or ECMO. Conclusions: (1) ECMO is useful for post-heart transplant circulatory suppo rt in infants with early graft failure. (2) All survivors were weaned in fe wer than 4 days. (3) Three-year survival of ECMO hospital survivors has bee n high, but neurologic complications are prevalent.